Cardiome Pharma Corp (NASDAQ:CRME)

9.78
Delayed Data
As of Feb 27
 +0.03 / +0.31%
Today’s Change
5.84
Today|||52-Week Range
11.31
+5.73%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues66.1M1.5M789.0K4.5M
 
 
 
 
 
Cost of Goods Sold0.0015.2M--936.0K
 
 
 
Depreciation And Amortization1.2M1.1M1.2M649.0K
 
 
 
 
 
 
Operating ExpensesGross Income64.9M-14.8M--2.9M
 
 
 
 
General Expenses28.2M11.5M15.6M16.9M
 
 
 
 
 
Research And Development15.3M--6.0M476.0K
 
 
 
 
Total Operating Expenses29.4M27.9M16.9M18.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income36.7M-26.4M-16.1M-14.0M
 
 
 
 
 
Extraordinary Credit0.000.0011.2M20.8M
 
 
 
Extraordinary Charge-25.0K-95.0K-10.0M-2.7M
 
 
 
 
 
Interest Expense On Debt2.0M2.2M4.3M87.0K
 
 
 
 
 
Other Expenses803.0K756.0K843.0K825.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income35.5M-27.9M-18.3M4.9M
 
 
 
 
 
Income Taxes0.000.000.00-102.0K
 
 
Net Income35.5M-27.9M-18.3M4.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.2M12.2M12.3M12.8M
 
 
 
 
 
Shares To Calculate EPS Diluted12.3M12.2M12.3M12.9M
 
 
 
 
 
 
Earnings Per ShareEPS$2.90-$2.30-$1.50$0.37
 
 
 
 
 
EPS Diluted$2.90-$2.30-$1.50$0.37
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account